vs
Astrana Health, Inc.(ASTH)与DXP ENTERPRISES INC(DXPE)财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是DXP ENTERPRISES INC的1.8倍($950.5M vs $527.4M),DXP ENTERPRISES INC净利率更高(4.3% vs 0.7%,领先3.6%),Astrana Health, Inc.同比增速更快(42.9% vs 12.0%),DXP ENTERPRISES INC自由现金流更多($34.5M vs $-6.0M),过去两年Astrana Health, Inc.的营收复合增速更高(53.3% vs 13.1%)
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商,主要服务全美符合联邦医保资格的老年群体,提供上门初级护理、慢性病管理及护理协调服务,致力于提升患者健康水平、降低不必要的医疗支出。
DXP Enterprises Inc.是一家领先的工业分销企业,提供维护、维修、运营(MRO)用品、流体处理设备、泵系统及相关技术服务,主要服务制造业、能源、矿业、建筑等领域客户,核心市场覆盖北美地区。
ASTH vs DXPE — 直观对比
营收规模更大
ASTH
是对方的1.8倍
$527.4M
营收增速更快
ASTH
高出30.9%
12.0%
净利率更高
DXPE
高出3.6%
0.7%
自由现金流更多
DXPE
多$40.4M
$-6.0M
两年增速更快
ASTH
近两年复合增速
13.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $950.5M | $527.4M |
| 净利润 | $6.6M | $22.8M |
| 毛利率 | — | 31.6% |
| 营业利润率 | 1.9% | 8.8% |
| 净利率 | 0.7% | 4.3% |
| 营收同比 | 42.9% | 12.0% |
| 净利润同比 | 184.4% | 6.9% |
| 每股收益(稀释后) | $0.12 | $1.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASTH
DXPE
| Q4 25 | $950.5M | $527.4M | ||
| Q3 25 | $956.0M | $513.7M | ||
| Q2 25 | $654.8M | $498.7M | ||
| Q1 25 | $620.4M | $476.6M | ||
| Q4 24 | $665.2M | $470.9M | ||
| Q3 24 | $478.7M | $472.9M | ||
| Q2 24 | $486.3M | $445.6M | ||
| Q1 24 | $404.4M | $412.6M |
净利润
ASTH
DXPE
| Q4 25 | $6.6M | $22.8M | ||
| Q3 25 | $373.0K | $21.6M | ||
| Q2 25 | $9.4M | $23.6M | ||
| Q1 25 | $6.7M | $20.6M | ||
| Q4 24 | $-7.8M | $21.4M | ||
| Q3 24 | $16.1M | $21.1M | ||
| Q2 24 | $19.2M | $16.7M | ||
| Q1 24 | $14.8M | $11.3M |
毛利率
ASTH
DXPE
| Q4 25 | — | 31.6% | ||
| Q3 25 | — | 31.4% | ||
| Q2 25 | — | 31.6% | ||
| Q1 25 | — | 31.5% | ||
| Q4 24 | — | 31.5% | ||
| Q3 24 | — | 30.9% | ||
| Q2 24 | — | 30.9% | ||
| Q1 24 | — | 30.0% |
营业利润率
ASTH
DXPE
| Q4 25 | 1.9% | 8.8% | ||
| Q3 25 | 2.0% | 8.5% | ||
| Q2 25 | 3.1% | 9.2% | ||
| Q1 25 | 3.3% | 8.5% | ||
| Q4 24 | 0.1% | 8.3% | ||
| Q3 24 | 5.9% | 8.4% | ||
| Q2 24 | 6.2% | 8.4% | ||
| Q1 24 | 7.5% | 7.1% |
净利率
ASTH
DXPE
| Q4 25 | 0.7% | 4.3% | ||
| Q3 25 | 0.0% | 4.2% | ||
| Q2 25 | 1.4% | 4.7% | ||
| Q1 25 | 1.1% | 4.3% | ||
| Q4 24 | -1.2% | 4.5% | ||
| Q3 24 | 3.4% | 4.5% | ||
| Q2 24 | 3.9% | 3.7% | ||
| Q1 24 | 3.7% | 2.7% |
每股收益(稀释后)
ASTH
DXPE
| Q4 25 | $0.12 | $1.38 | ||
| Q3 25 | $0.01 | $1.31 | ||
| Q2 25 | $0.19 | $1.43 | ||
| Q1 25 | $0.14 | $1.25 | ||
| Q4 24 | $-0.14 | $1.28 | ||
| Q3 24 | $0.33 | $1.27 | ||
| Q2 24 | $0.40 | $1.00 | ||
| Q1 24 | $0.31 | $0.67 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $303.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $498.4M |
| 总资产 | $2.2B | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ASTH
DXPE
| Q4 25 | $429.5M | $303.8M | ||
| Q3 25 | $463.4M | $123.8M | ||
| Q2 25 | $342.1M | $112.9M | ||
| Q1 25 | $260.9M | $114.3M | ||
| Q4 24 | $290.8M | $148.3M | ||
| Q3 24 | $350.3M | $35.0M | ||
| Q2 24 | $327.7M | $49.9M | ||
| Q1 24 | $337.3M | $139.7M |
股东权益
ASTH
DXPE
| Q4 25 | $779.3M | $498.4M | ||
| Q3 25 | $775.5M | $488.3M | ||
| Q2 25 | $765.5M | $468.1M | ||
| Q1 25 | $745.4M | $444.7M | ||
| Q4 24 | $712.7M | $422.8M | ||
| Q3 24 | $704.6M | $402.4M | ||
| Q2 24 | $678.9M | $384.7M | ||
| Q1 24 | $653.5M | $375.5M |
总资产
ASTH
DXPE
| Q4 25 | $2.2B | $1.7B | ||
| Q3 25 | $2.2B | $1.4B | ||
| Q2 25 | $1.4B | $1.4B | ||
| Q1 25 | $1.3B | $1.4B | ||
| Q4 24 | $1.4B | $1.3B | ||
| Q3 24 | $1.3B | $1.2B | ||
| Q2 24 | $1.3B | $1.2B | ||
| Q1 24 | $1.2B | $1.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $37.8M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $34.5M |
| 自由现金流率自由现金流/营收 | -0.6% | 6.5% |
| 资本支出强度资本支出/营收 | 0.3% | 0.6% |
| 现金转化率经营现金流/净利润 | -0.44× | 1.65× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $54.0M |
8季度趋势,按日历期对齐
经营现金流
ASTH
DXPE
| Q4 25 | $-2.9M | $37.8M | ||
| Q3 25 | $10.0M | $34.9M | ||
| Q2 25 | $90.9M | $18.6M | ||
| Q1 25 | $16.6M | $3.0M | ||
| Q4 24 | $-10.9M | $32.1M | ||
| Q3 24 | $34.0M | $28.3M | ||
| Q2 24 | $23.2M | $14.7M | ||
| Q1 24 | $6.0M | $27.0M |
自由现金流
ASTH
DXPE
| Q4 25 | $-6.0M | $34.5M | ||
| Q3 25 | $7.4M | $28.1M | ||
| Q2 25 | $89.5M | $8.3M | ||
| Q1 25 | $13.6M | $-16.9M | ||
| Q4 24 | $-13.5M | $22.7M | ||
| Q3 24 | $31.7M | $24.4M | ||
| Q2 24 | $20.4M | $5.9M | ||
| Q1 24 | $5.6M | $24.1M |
自由现金流率
ASTH
DXPE
| Q4 25 | -0.6% | 6.5% | ||
| Q3 25 | 0.8% | 5.5% | ||
| Q2 25 | 13.7% | 1.7% | ||
| Q1 25 | 2.2% | -3.6% | ||
| Q4 24 | -2.0% | 4.8% | ||
| Q3 24 | 6.6% | 5.2% | ||
| Q2 24 | 4.2% | 1.3% | ||
| Q1 24 | 1.4% | 5.8% |
资本支出强度
ASTH
DXPE
| Q4 25 | 0.3% | 0.6% | ||
| Q3 25 | 0.3% | 1.3% | ||
| Q2 25 | 0.2% | 2.1% | ||
| Q1 25 | 0.5% | 4.2% | ||
| Q4 24 | 0.4% | 2.0% | ||
| Q3 24 | 0.5% | 0.8% | ||
| Q2 24 | 0.6% | 2.0% | ||
| Q1 24 | 0.1% | 0.7% |
现金转化率
ASTH
DXPE
| Q4 25 | -0.44× | 1.65× | ||
| Q3 25 | 26.69× | 1.61× | ||
| Q2 25 | 9.65× | 0.79× | ||
| Q1 25 | 2.48× | 0.14× | ||
| Q4 24 | — | 1.50× | ||
| Q3 24 | 2.11× | 1.34× | ||
| Q2 24 | 1.21× | 0.88× | ||
| Q1 24 | 0.40× | 2.38× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
DXPE
| Service Centers | $356.2M | 68% |
| Innovative Pumping Solutions | $110.0M | 21% |
| Supply Chain Services | $61.2M | 12% |